We are analyzing https://link.springer.com/article/10.1007/s12032-012-0334-5.

Title:
High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer | Medical Oncology
Description:
With growing evidence on the role of inflammation in carcinogenesis, the presence of a systemic inflammatory response has been proposed as having prognostic significance in a wide range of cancers. The aim of the study was to assess the value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in predicting disease-specific survival (DSS) in patients with oral cancer undergoing preoperative chemoradiotherapy. A cohort of 97 patients with locally advanced oral squamous cell carcinoma receiving preoperative chemoradiotherapy was retrospectively examined. The impact of NLR and other potential prognostic factors on DSS was assessed with the Kaplan–Meier method and multivariate Cox regression analysis. Sixty-nine patients had a high pretreatment NLR, with NLR > 1.9 considered as high according to receiver operating characteristic curve analysis. In univariate analysis, high pretreatment NLR (p = 0.018), positive perineural invasion (p < 0.001) and advanced pathologic TNM stage after neoadjuvant therapy (p < 0.001) were predictive of shorter DSS. In multivariate analysis, advanced pathologic TNM stage after neoadjuvant therapy (HR 1.71, 95 % CI 1.17–2.48, p = 0.005), positive perineural invasion (HR 3.67, 95 % CI 1.11–12.13, p = 0.033) and high pretreatment NLR (HR 10.37, 95 % CI 1.28–84.08, p = 0.029) remained independently associated with poor DSS. A high pretreatment NLR is a significant independent predictor of shorter DSS in patients with oral cancer receiving preoperative chemoradiotherapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

article, google, scholar, cancer, pubmed, patients, oral, cas, ratio, oncol, carcinoma, prognostic, advanced, cell, neutrophiltolymphocyte, pretreatment, squamous, analysis, high, survival, med, independent, nlr, preoperative, perisanidis, inflammation, access, neutrophil, lymphocyte, head, neck, privacy, cookies, content, poor, role, dss, chemoradiotherapy, prognosis, metastatic, clin, publish, search, medical, diseasespecific, locally, factors, predicts, res, lee,

Topics {✒️}

month download article/chapter poor disease-specific survival predicting disease-specific survival preoperative hematologic markers serum c-reactive protein small-cell lung cancer inflammation-based prognostic indices independent prognostic factor full article pdf lymphocyte ratio predicts google scholar privacy choices/manage cookies prognostic factor malignant pleural mesothelioma neutrophil-lymphocyte ratio elevated preoperative neutrophil cancer-related inflammation potential prognostic factors independent prognostic factors locally advanced head high blood neutrophil pretreatment serum neutrophil absolute lymphocyte count systemic inflammatory response postoperative disease recurrence hypopharyngeal cancer treated advanced colorectal cancer related subjects high-dose interleukin-2 oral pathol med pretreatment neutrophil count european economic area kaplan–meier method positive perineural invasion defining risk levels concurrent postoperative radiation tumors releasing interleukin-8 enhanced inflammatory activity acute myocardial infarction ovarian cancer independent article perisanidis clin cancer res conditions privacy policy nat rev immunol advanced cancer patients inflammation based factors high pretreatment nlr check access instant access potential clinical applications

Questions {❓}

Inflammation and cancer: back to Virchow?
Stat3: linking inflammation to epithelial cancer—more than a “gut” feeling?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer
         description:With growing evidence on the role of inflammation in carcinogenesis, the presence of a systemic inflammatory response has been proposed as having prognostic significance in a wide range of cancers. The aim of the study was to assess the value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in predicting disease-specific survival (DSS) in patients with oral cancer undergoing preoperative chemoradiotherapy. A cohort of 97 patients with locally advanced oral squamous cell carcinoma receiving preoperative chemoradiotherapy was retrospectively examined. The impact of NLR and other potential prognostic factors on DSS was assessed with the Kaplan–Meier method and multivariate Cox regression analysis. Sixty-nine patients had a high pretreatment NLR, with NLR > 1.9 considered as high according to receiver operating characteristic curve analysis. In univariate analysis, high pretreatment NLR (p = 0.018), positive perineural invasion (p < 0.001) and advanced pathologic TNM stage after neoadjuvant therapy (p < 0.001) were predictive of shorter DSS. In multivariate analysis, advanced pathologic TNM stage after neoadjuvant therapy (HR 1.71, 95 % CI 1.17–2.48, p = 0.005), positive perineural invasion (HR 3.67, 95 % CI 1.11–12.13, p = 0.033) and high pretreatment NLR (HR 10.37, 95 % CI 1.28–84.08, p = 0.029) remained independently associated with poor DSS. A high pretreatment NLR is a significant independent predictor of shorter DSS in patients with oral cancer receiving preoperative chemoradiotherapy.
         datePublished:2013-01-06T00:00:00Z
         dateModified:2013-01-06T00:00:00Z
         pageStart:1
         pageEnd:8
         sameAs:https://doi.org/10.1007/s12032-012-0334-5
         keywords:
            Neutrophil-to-lymphocyte ratio
            Prognostic marker
            Oral cancer
            Disease-specific survival
            Oncology
            Hematology
            Pathology
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-012-0334-5/MediaObjects/12032_2012_334_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-012-0334-5/MediaObjects/12032_2012_334_Fig2_HTML.gif
         isPartOf:
            name:Medical Oncology
            issn:
               1559-131X
               1357-0560
            volumeNumber:30
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Christos Perisanidis
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Gabriela Kornek
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Department of Medicine I, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Paul W. Pöschl
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Daniel Holzinger
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Katharina Pirklbauer
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christian Schopper
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rolf Ewers
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer
      description:With growing evidence on the role of inflammation in carcinogenesis, the presence of a systemic inflammatory response has been proposed as having prognostic significance in a wide range of cancers. The aim of the study was to assess the value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in predicting disease-specific survival (DSS) in patients with oral cancer undergoing preoperative chemoradiotherapy. A cohort of 97 patients with locally advanced oral squamous cell carcinoma receiving preoperative chemoradiotherapy was retrospectively examined. The impact of NLR and other potential prognostic factors on DSS was assessed with the Kaplan–Meier method and multivariate Cox regression analysis. Sixty-nine patients had a high pretreatment NLR, with NLR > 1.9 considered as high according to receiver operating characteristic curve analysis. In univariate analysis, high pretreatment NLR (p = 0.018), positive perineural invasion (p < 0.001) and advanced pathologic TNM stage after neoadjuvant therapy (p < 0.001) were predictive of shorter DSS. In multivariate analysis, advanced pathologic TNM stage after neoadjuvant therapy (HR 1.71, 95 % CI 1.17–2.48, p = 0.005), positive perineural invasion (HR 3.67, 95 % CI 1.11–12.13, p = 0.033) and high pretreatment NLR (HR 10.37, 95 % CI 1.28–84.08, p = 0.029) remained independently associated with poor DSS. A high pretreatment NLR is a significant independent predictor of shorter DSS in patients with oral cancer receiving preoperative chemoradiotherapy.
      datePublished:2013-01-06T00:00:00Z
      dateModified:2013-01-06T00:00:00Z
      pageStart:1
      pageEnd:8
      sameAs:https://doi.org/10.1007/s12032-012-0334-5
      keywords:
         Neutrophil-to-lymphocyte ratio
         Prognostic marker
         Oral cancer
         Disease-specific survival
         Oncology
         Hematology
         Pathology
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-012-0334-5/MediaObjects/12032_2012_334_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-012-0334-5/MediaObjects/12032_2012_334_Fig2_HTML.gif
      isPartOf:
         name:Medical Oncology
         issn:
            1559-131X
            1357-0560
         volumeNumber:30
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Christos Perisanidis
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Gabriela Kornek
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Department of Medicine I, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Paul W. Pöschl
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Daniel Holzinger
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Katharina Pirklbauer
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christian Schopper
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rolf Ewers
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Medical Oncology
      issn:
         1559-131X
         1357-0560
      volumeNumber:30
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Medical University of Vienna
      address:
         name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Department of Medicine I, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Christos Perisanidis
      affiliation:
            name:Medical University of Vienna
            address:
               name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Gabriela Kornek
      affiliation:
            name:Medical University of Vienna
            address:
               name:Department of Medicine I, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
      name:Paul W. Pöschl
      affiliation:
            name:Medical University of Vienna
            address:
               name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
      name:Daniel Holzinger
      affiliation:
            name:Medical University of Vienna
            address:
               name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
      name:Katharina Pirklbauer
      affiliation:
            name:Medical University of Vienna
            address:
               name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
      name:Christian Schopper
      affiliation:
            name:Medical University of Vienna
            address:
               name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
      name:Rolf Ewers
      affiliation:
            name:Medical University of Vienna
            address:
               name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
      name:Department of Medicine I, Medical University of Vienna, Vienna, Austria
      name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
      name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
      name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
      name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
      name:Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(142)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.1s.

LINK . SPRINGER . COM {}